Although originally described as a regulator of glycogen synthase involved in the development of diabetes and cancer (Ali et al., 2001; Luo, 2009), GSK-3beta plays a significant role in modulating the development of sepsis and shock (Dugo et al., 2007). Here, GSK3B is linked to cancer.